HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International Drives C&D Sales, NPA On WIC, Recalls: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

Church & Dwight reports 12% growth in consumer business abroad; functional foods marketer Soylent receives $50m in funding round; Herbalife Protein Bar – Peanut Butter and other recalls; and more news in brief.

You may also be interested in...



C&D Oral Care Marketing Flows To Professionals Through WaterPik

Church & Dwight acquires Water Pik Inc. for $1bn in a deal that will give the Arm & Hammer marketer access to the dental professional market, expand its oral care device business and stretch international distribution of water flosser products which already have 90% US market share.

C&D Oral Care Marketing Flows To Professionals Through WaterPik

Church & Dwight acquires Water Pik Inc. for $1bn in a deal that will give the Arm & Hammer marketer access to the dental professional market, expand its oral care device business and stretch international distribution of water flosser products which already have 90% US market share.

Church & Dwight Hooks Future Growth To International And Internet Sales

The growth of e-commerce and other digital capabilities is introducing online search engines' own brands as competition for Church & Dwight's and other firms' dietary supplements and personal and household care products, says CEO Matthew Farrell.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109235

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel